Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Biomedical Research topic
No spam. Unsubscribe anytime.
UAMS receives $10.5 million NIH award to develop biomarker tests for disease, including cancer
Summary
University of Arkansas for Medical Sciences staff told a joint legislative public-health committee that the National Institutes of Health awarded UAMS a $10.5 million grant to support development of biomarker testing to detect and treat human diseases, including cancer.
The University of Arkansas for Medical Sciences was awarded a $10.5 million grant from the National Institutes of Health to support development of biomarker testing for human diseases, including cancer, committee presenters said at a joint Senate and House public-health meeting Dec. 8 in Little Rock.
Alan Tackett, Ph.D., deputy director of the Winthrop P. Rockefeller Cancer Institute at UAMS, and Andy Davis, vice chancellor of institutional relations and chief government affairs officer at UAMS, presented an overview of the grant and its intended purpose: to advance biomarker testing that can allow physicians to detect and treat disease earlier. The presenters described the award as a research grant from the National Institutes of Health to the Winthrop P. Rockefeller Cancer Institute at UAMS.
Committee members were given a high-level summary of the grant’s focus on biomarker development for human diseases, including cancer. The transcript records an overview was provided but does not specify research subprojects, timelines, personnel allocations, or whether the award includes multiple funding phases; those details were not specified in the presentation.
No formal committee action on the grant was recorded in the meeting minutes; the presentation was informational. The committee proceeded to other agenda items after the overview.
